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Objectives – Relaxin induces the matrix metalloproteinase MMP-1 (collagenase-1)
in TMJ fibrocartilaginous cells, and this response is potentiated by b-estradiol. We
identified the MMP-1 promoter sites and transcription factors that are induced by
relaxin with or without b-estradiol in fibrocartilaginous cells.
Material and Methods – Early passage cells were transiently transfected with the
pBLCAT2 plasmid containing specific segments of the human MMP-1 promoter
regulating the chloramphenicol acyl transferase (CAT) gene and co-transfected with
a plasmid containing the b-galactosidase gene. The cells were cultured in serum-
free medium alone or medium containing 0.1 ng ⁄ ml relaxin, or 20 ng ⁄ ml b-estradiol
or both hormones, and lysates assayed for CAT and b-galactosidase activity.
Results – Cells transfected with the )1200 ⁄ )42 or )139 ⁄ )42 bp MMP-1 promoter-
reporter constructs showed 1.5-fold and 3-fold induction of CAT by relaxin in the
absence or presence of b-estradiol, respectively. Relaxin failed to induce CAT in the
absence of the )137 ⁄ )69 region of the MMP-1 promoter, which contains the AP-
1-and PEA3-binding sites. Using wild type or mutated minimal AP-1 and PEA-3
promoters we found that both these promoter sites are essential for the induction of
MMP-1 by relaxin. The mRNAs for transcription factors c-fos and c-jun, which
together form the AP-1 heterodimer, and Ets-1 that modulates the PEA-3 site, were
upregulated by relaxin or b-estradiol plus relaxin.
Conclusion – These studies show that both the AP-1 and PEA-3 promoter sites are
necessary for the induction of MMP-1 by relaxin in fibrocartilaginous cells.
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Introduction
Because of the age and gender distribution of temporomandibular joint
disorders (TMDs) primarily in women of reproductive age, we have
been exploring the role of the female sex hormones estrogen and
relaxin in contributing to these diseases. We have found that relaxin
induces the tissue degrading matrix metalloproteinases (MMPs) MMP-1
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(collagenase-1), -3 (stromelysin-1), -9 (92 kDa
gelatinase) and -13 (collagenase-3) in TMJ disc fibro-
cartilaginous cells from mice and rabbits (1–3). Fur-
thermore, b-estradiol enhances the induction of these
proteinases by relaxin. More recently, we have found
that TMJ disc cells express both estrogen receptors (ER) -
a and -b as well as the relaxin receptors, relaxin family
peptide (RXFP) -1 and -2 pointing to a potential cellular
activation mechanism by which their ligands, acting via
some or all of these receptors, may induce MMPs. While
the presence of these receptors on TMJ cells suggests
their likely contribution to MMP induction, the signaling
mechanisms and basis for the subsequent transcrip-
tional regulation of MMPs by relaxin remains to be
characterized.
Previous studies have shed some light on the possible
transcriptional regulatory mechanisms of MMP-1 gene
expression by hormones and growth factors, suggesting
a crucial role of the 5¢ flanking sequence containing the
TPA and the oncogene responsive unit (TORU)
comprised of the activator protein-1 (AP-1) motif
[5¢-TGAGTCA-3¢] and the polyoma enhancer activator
protein-3 (PEA-3) motif [5¢-GAGGATGT-3¢] in the pro-
moter region of MMP-1 gene (4, 5). These studies have
demonstrated that several stimuli including phorbol
esters are capable of modulating MMP-1 gene expres-
sion via signaling pathways in which transcriptional
factors in the fos and jun families bind to the AP-1
motif while Ets family binds to the PEA-3 motif in the
promoter region of MMP-1 thereby inducing the tran-
scription of MMP-1 (5, 6). Although both the AP-1 and
PEA-3 motifs of the MMP-1 promoter appear to play an
important role in the transcriptional regulation of
MMP-1, the extent of their involvement varies sub-
stantially depending on the cell type and the stimulus
used. Thus for example, both AP-1 and PEA-3 motifs
are necessary for the induction of MMP-1 promoter
activity in fibroblasts or HeLa cells exposed to fibro-
nectin fragments and PMA, respectively (7, 8). In con-
trast, while the AP-1 motif is necessary for mediating
the induction of MMP-1 transcriptional activity in TPA-
treated fibroblasts and insulin-treated HeLa cells, the
PEA-3 motif acts as an enhancer in inducing MMP-1
transcription in these cells (9, 10).
Other regulatory mechanisms may also be involved
in the transcriptional activity of MMP-1 gene (11–13).
Thus, MMP-1 promoter activity is induced and main-
tained in the absence of a functional AP-1 motif in
PMA-treated U937 cells undergoing differentiation
from monocytes to macrophages in vitro (6), suggest-
ing that the distal promoter sequence of MMP-1
potentially regulates MMP-1 transcriptional activity in
an AP-1 independent manner. Furthermore, the stim-
ulation of MMP-1 promoter activity by v-src in fibro-
blasts requires PEA-3 and STAT motifs rather than AP-1
motif in MMP-1 promoter (6, 14). Together, these
findings suggest that the regulatory role of AP-1 and
PEA-3 motifs in mediating the transcriptional activity
of MMP-1 is likely cell and tissue specific. Moreover,
the location of individual AP-1 and PEA-3 motifs and
the sequences surrounding them may also contribute
to the determination of the function of these elements
in regulating the transcriptional activity of the MMP-1
gene.
Because of the known differences in the MMP-1
promoter elements involved in the transcription of its
gene and the lack of information on how relaxin reg-
ulates the expression of this gene, here we determined
the transcriptional regulatory mechanisms for MMP-1




All animal experiments were conducted with the
approval of the Institutional Review Board. Twenty-
week-old female New Zealand white rabbits (Oryctola-
gus cuniculus) were obtained from Nita Bell laboratories
(Hayward, CA, USA). All reagents were from Sigma
Chemical Company (St. Louis, MO, USA) unless other-
wise mentioned. Recombinant human relaxin was
kindly provided by Connetics Corporation (Palo Alto,
CA, USA). All restriction enzymes were purchased from
Promega Corporation (Madison, WI, USA).
Promoter-reporter constructs
Three human MMP-1 promoter constructs, kindly
provided by Peter Herrlich and Hans Rahmsdorf
(Institution Karlsruhe, Germany), were used in this
study. The constructs contain MMP-1 promoter
sequences )1200 ⁄ )42 bp, )139 ⁄ )42 or )66 ⁄ )42 bp
placed upstream of the minimal tyrosine kinase pro-
moter and the bacterial gene for chloramphenicol
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acetyl transferase (CAT) in the plasmid pBLCAT2 (15).
The plasmids mAP-1col-tkCAT, mPEA-3col-tkCAT and
WTcol-tkCAT were obtained from Dr. Zena Werb
(University of California San Francisco, CA, USA) (8).
These were previously constructed using synthetic oli-
gonucleotides containing the AP-1 and PEA-3 sites (15).
The construct WTcol-tkCAT has a minimal )90 ⁄ )67 bp
segment of the MMP-1 promoter containing the AP-1
and the PEA-3 sites. The constructs mAP-1col-tkCAT
contains a mutated AP-1 site with an AT to TG substi-
tution in the minimal )90 ⁄ )67 bp minimal promoter.
mPEA-3col-tkCAT contains a G to A substitution in the
PEA-3 site of this minimal promoter. These mutations
produce oligonucleotides that do not complex with
AP-1 or Ets-1, respectively. A vector with the bacterial
lac Z gene that codes for b-galactosidase (b-gal) and is
driven by the SV-40 early promoter and enhancer was
utilized as a positive control.
Isolation and culture of cells
The cells were isolated from rabbit TMJ and cultured as
described previously (1, 16), and cultured in a-MEM
supplemented with 10% fetal calf serum. After 2 weeks,
the cells were trypsinized and replated. Cells in pas-
sages 3–5 plated at a density of 50 000 cells ⁄ cm2 were
used in subsequent experiments at 70% confluence.
Transfections
Plasmids containing the promoter-reporter constructs
were purified by Qiagen Maxi Plasmid purification kit
(Qiagen Corporation, Valencia, CA, USA). Purified
plasmid DNA (2–8 mg) was mixed with 25 ml CaCl2,
and incubated with the cells for 4 h, and washed with
phosphate buffered saline (PBS). Cells were maintained
in either serum free medium (a-MEM + 0.2% lactal-
bumin hydrolysate; LAH) (control) or in medium con-
taining b-estradiol (20 ng ⁄ ml), or relaxin (0.1 ng ⁄ ml) or
relaxin plus b-estradiol or 12-O-tetradeconyl-phorbol-
13-acetate (TPA; 50 ng ⁄ ml) for 12 h. TPA was used as a
positive control in all experiments as its induction of
MMP-1 promoter sites has been well characterized (7).
For dose response experiments, 0, 0.01, 0.1 and 1 ng ⁄ ml
of relaxin was utilized on cells transfected with the
WTcol-tkCAT construct. Cell culture medium was
collected, the cells were washed and incubated with
reporter lysis buffer (Promega) for 15 min and scraped.
b-Galactosidase activity was assayed by its hydrolysis
of the substrate o-nirophenyl-a-D-galactopyranoside
(Promega) and read at 420 nm (Spectramax M2,
Molecular Devices, Sunnyvale, CA, USA) to monitor the
efficiency of transfections. CAT activity was determined
by anti-CAT-digoxygenin ELISA as per manufacturers
instructions (Boehringer Mannheim, Indianapolis, IN,
USA).
Preparation of 32P-labeled cDNA probe
The 2.2–2.3 kbp c-fos cDNA was released from the
plasmid pSP64 (Promega) by restriction digestion with
EcoRI. The c-jun cDNA was obtained from plasmid
T7c-jun by restriction digestion with EcoRI ⁄ HindIII to
release a 2.3 kbp piece. PEA-3 cDNA was prepared by
releasing 1.6 kbp EcoRI fragment from the plasmid
pGEX-PEA-3 (American Type Culture Collection,
Manassus, VA, USA). The cDNAs were purified on a 1%
low melting agarose, and 10 ng each of cDNA was la-
beled with 32P-dCTP using Rediprime DNA labeling kit
(Amersham Life Sciences, Arlington Heights, IL, USA).
The mixture was incubated for 10 min and the reaction
stopped by adding EDTA. The probes were purified
using Chroma Spin columns (Clontech, Palo Alto, CA,
USA).
RNA extraction and northern analysis
Total RNA was extracted from disc fibrocartilaginous
cells after 30 min in control or hormone-containing
media as described previously (1), and the yield and
purity of RNA determined by UV spectroscopy. The RNA
(15 ng) was loaded and electrophoresed on a 1% dena-
turing agarose-formaldehyde gel and transferred to a
nylon membrane. The membrane was hybridized with
the 32P-labeled cDNA probes for c-fos, c-jun, Ets-1 and
glyceraldehyde-3-phosphate dehydrogenase (G3PDH)
and washed. The signal was detected by autoradio-
graphy and quantitated by video densitometry.
Substrate zymography
Collagenase in cell-conditioned medium was
monitored by gelatin substrate zymograms as described
previously (1). In brief, the medium standardized by
total protein was mixed with 4· sample buffer and
electrophoresed on a 10% SDS-polyacrylamide gel
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containing 2 mg ⁄ ml gelatin. After washing the gel with
2.5% Triton X-100, the gels were incubated for 20 h at
37C. The gels were stained with Coomassie blue, and
destained to visualize proteolytic activity.
Statistical analysis
Each experiment was performed in quadruplicate. The
mean (±SE) fold induction of CAT standardized to b-gal
for each of the treatments relative to the control base-
line was analyzed with an ANOVA and intergroup differ-
ences determined by Scheffes multiple comparison
test with the level of significance set at p < 0.05.
Results
Relaxin induces c-fos, c-jun and Ets-1 mRNAs
We initially studied the modulation of the mRNAs for
the transcription factors, Fos and Jun, which form the
AP-1 heterodimer, and that for Ets-1. Relaxin and
b-estradiol plus relaxin caused a 1.7- and 1.8-fold
increase in c-fos levels over controls, respectively
(Fig. 1A, B). c-jun mRNA was increased 2-fold over
control levels by relaxin both in the presence and
absence of b-estradiol (Fig. 1A, C). b-estradiol alone
also caused an increase in both c-fos and c-jun mRNAs,
although the magnitude of this increase was somewhat
less than that with relaxin. Ets-1 mRNA was increased
slightly by b-estradiol or relaxin alone, while it showed
a 1.8-fold induction with relaxin and b-estradiol
combined (Fig. 1A, D). As expected, TPA produced
substantial increases in the levels of mRNAs for all
three-transcription factors.
Regulation of the human MMP-1 gene promoter by relaxin requires
the )139 ⁄ )67 bp region
Cells transfected with the plasmid pBLCAT2 contain-
ing the )1200 ⁄ )42 bp segment of the collagenase
promoter showed statistically significant 1.7-fold and
2.8-fold induction of CAT by relaxin alone or by
b-estradiol plus relaxin, respectively (Fig. 2B). In cells
transfected with the )139 ⁄ )42 construct, there was a
statistically significant 1.6-fold induction of CAT
expression by relaxin alone and a 3.6-fold induction
by b-estradiol plus relaxin. TPA produced substantial
induction, while b-estradiol alone failed to induce
the CAT gene linked to the )1200 ⁄ )42 bp and
)139 ⁄ )42 bp promoter regions. CAT expression was
Fig. 1. Relaxin with or without b-estradiol
upregulates c-fos, c-jun and Ets-1 mRNAs in
fibrocartilaginous cells. (A) RNA extracted
from cells exposed to control medium (Ct) or
medium with b-estradiol (Es, 20 ng ⁄ ml) and ⁄
or relaxin (R, 0.1 ng ⁄ ml) or TPA (50 ng ⁄ ml)
was subjected to Northern blot analysis for c-
jun, c-fos, Ets-1 or G3PDH. Histograms of the
mean (±SE) fold-induction of c-fos (B), c-jun
(C) and Ets-1 (D) determined by video den-
sitometry and standardized to G3PDH by the
various treatments relative to control base-
line levels were plotted from four experi-
ments.
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not induced by any of the hormone treatments or by
TPA in cells transfected with constructs containing
only )66 ⁄ )42 bp region, suggesting that the deleted
)139 to )67 bp promoter region contains sites
responsive to relaxin. Findings showing the induction
of 53 ⁄ 58 kDa gelatinolytic activity (collagenase) by
relaxin in the absence or presence of b-estradiol and
by TPA, but not by b-estradiol alone were consistent
with the CAT promoter data and also shows that this
MMP is indeed modulated by these treatments
(Fig. 2C).
MMP-1 induction by relaxin requires both the AP-1 and PEA-3
promoter sites
As the )139 ⁄ )43 bp region of the MMP-1 promoter
contains the AP-1 and PEA-3 motifs, and because our
findings demonstrated that relaxin induces the tran-
scription factors for these sites, we studied the precise
contribution of these two sites in the regulation of this
gene by relaxin by utilizing the mutated forms of these
cis-acting elements within the context of a minimal
)90 ⁄ )67 bp promoter (Fig. 3A). Cells transfected with
the wild type construct containing the minimal MMP-1
AP-1 and PEA-3 promoter sites responded to relaxin in
the absence or presence of b-estradiol with a 1.7-fold
and a 2.6-fold increase in CAT expression, respectively,
over control levels (Fig. 3B). There was no induction of
the wild type promoter in response to b-estradiol alone.
In disc cells transfected with the construct mAP-1col-
tkCAT or mPEA-3col-tkCAT, there was no modulation
of CAT activity in response to any of the hormone
treatments or TPA.
Relaxins regulation of the minimal wild type MMP-1 promoter
by relaxin is dose dependent
The specificity of the responsiveness of the minimal
WTcol-tkCAT construct to relaxin was demonstrated
by the dose-dependent induction of CAT activity by
relaxin and b-estradiol plus relaxin (Fig. 3C). Consis-
tent with our previous findings on the dose dependent
induction of collagenase by relaxin or b-estradiol plus
relaxin (1), the peak induction of CAT occurred at
1 ng ⁄ ml of relaxin in the absence of b-estradiol and
0.1 ng ⁄ ml relaxin when b-estradiol was present in the
medium.
Discussion
In this study, we examined the transcriptional regula-
tory mechanisms of MMP-1 gene induction by relaxin,
a member of the insulin superfamily, in the absence or
presence of b-estradiol in disc fibrocartilaginous cells.
Our data demonstrated that relaxins induction of
the transcriptional activity of )1200 ⁄ )43 bp or )139 ⁄
)43 bp CAT-linked human MMP-1 promoters is pre-
ceded by the upregulation of c-fos, c-jun and Ets-1
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Fig. 2. Regulation of human MMP-1 gene promoter by relaxin without or with b-estradiol requires the )139 ⁄ )67 bp motif. Cell lysates from
cells transiently transfected with the )1200 ⁄ )42 or )139 ⁄ )42 or )66 ⁄ )42 bp human MMP-1 promoter-CAT constructs (A) and exposed to
control medium (Ct) or medium containing b-estradiol (Es) and ⁄ or relaxin (R) or TPA were assayed for b-gal and CAT. (B) The histogram for
mean (±SE) fold-induction of CAT ⁄ b-gal for each treatment relative to controls was plotted for four experiments. (C) Gelatin-substrate
zymography on cell-conditioned medium was used to visualize the changes in levels of endogenously expressed presumptive MMP-1 (arrow).
(*p < 0.05, **p < 0.005, ***p < 0.0005).
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increased the sensitivity of the fibrocartilaginous cells
to relaxin such that the induction of these transcription
factors and promoter constructs by relaxin was higher
in the presence than in the absence of b-estradiol.
Using wild type minimal AP-1 and PEA-3 promoter or
this promoter with mutated AP-1 or mutated PEA-3
motifs, we found that both AP-1 and PEA-3 regions of
the MMP-1 promoter are required and essential for full
activation of MMP-1 transcriptional activity by relaxin.
The response of MMP-1 to relaxin in fibrocartilaginous
cells transfected with the wild type promoter construct
was dose-dependent and potentiated by b-estradiol.
b-estradiol alone failed to induce CAT expression in
any of the promoter-reporter constructs. These find-
ings are consistent with our previous observations on
the modulation of MMP-1 expression by relaxin in
unprimed and b-estradiol-primed fibrocartilaginous
cells (1).
The insulin superfamily, including insulin, insulin-
like growth factors, and relaxin, is a family of small,
structurally related peptides that act on a variety of
mammalian cells in endocrine, paracrine and autocrine
manner to regulate cell proliferation, apoptosis, trans-
formation and differentiation (17–20). Relaxin has also
been shown to play an essential role in extracellular
matrix turnover in the uterus, pubic symphysis, and
fibrocartilage of synovial joints by modulating the
expression of MMPs (1, 3, 21). Our data provides the
first evidence that the transcriptional regulation of
MMP-1 by relaxin requires both the AP-1 and PEA-3
binding motifs. Our finding that the AP-1 motif is
required and essential for the induction of MMP-1 by
relaxin is consistent with previous studies showing that
the transcriptional regulation of MMP-1 by insulin and
phorbol esters in HeLa cells requires the AP-1 site (9).
However, in contrast to our findings that the mutation
of the Ets-1 transcriptional factor-binding PEA-3 motif
results in a complete abrogation of MMP-1 transcrip-
tion by relaxin in fibrocartilaginous disc cells, the
mutation of this motif failed to completely neutralize
the stimulatory effect of insulin on MMP-1 expression
in HeLa cells. Recent studies also indicate that while
the transcriptional regulation of MMP-1 by insulin is
largely mediated through an AP-1 motif, multiple
MMP-1 promoter elements are required for the full
stimulatory effect of insulin on MMP-1 expression (22).
The variability in MMP-1 transcriptional regulatory









































































Fig. 3. Regulation of the human MMP-1 gene promoter by relaxin without or with b-estradiol requires both the AP-1 and PEA-3 motifs. Cell
lysates from cells transiently transfected with the wild type minimal )90 ⁄ )67 bp segment of the MMP-1 promoter containing the AP-1 and the
PEA-3 sites (WTcol-tkCAT, WT) or this promoter with a mutated AP-1 site (mAP-1col-tkCAT, mAP-1) or mutated PEA-3 sites (mPEA-3col-
tkCAT, mPEA-3) (A) and cotransfected with pSV-b-gal vector were assayed as described in Fig. 2. (B) Histogram for mean (±SE) fold induction
of CAT ⁄ b-gal for each of the treatments relative to controls was plotted for four experiments. (C) Relaxin dose-response experiments were
performed by transfecting disc fibrocartilaginous cells with the WTcol-tkCAT promoter, exposing them to increasing concentrations of relaxin
with or without b-estradiol and assaying as described above. (*p < 0.05, **p < 0.005, ***p < 0.0005).
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several reasons, such as differences in cell types,
stimulating agent, downstream signaling cascade,
promoter context, AP-1 flanking sequences, and
accessory elements that modulate the signaling via
these two motifs (22).
The AP-1 motif, to which the members of Fos and
Jun transcription factor families bind, and PEA-3 motif,
to which the Ets transcription factor family bind, are
typically present in the promoters of inducible MMPs
and TIMP genes, and are essential elements for their
transcriptional activation. Individual AP-1 and PEA-3
elements often play distinct roles in basal and induced
transcription, and this may be a function of specific
transcription factors that bind to these motifs. The
MMP-1 gene contains adjacent AP-1 and PEA-3 motifs
that are proximal to the transcriptional start codon.
These motifs are required for activation of the pro-
moter by transforming oncogenes and tumor promot-
ing phorbol esters (4, 6, 14). In the present study, we
found that the induction of MMP-1 transcriptional
activity was preceded by the upregulation of the genes
for the transcriptional factors, c-fos, c-jun and Ets-1 in
fibrocartilaginous disc cells stimulated by relaxin or
relaxin plus b-estradiol. These results indicate that
these transcription factors likely act as mediators that
converge the variety of stimulatory signals to the DNA
binding motifs AP-1 and PEA-3 in the MMP-1 pro-
moter, and cause the subsequent increase in MMP-1
transcriptional activity. This concept is confirmed by
previous studies in which the AP-1 motif in the MMP-1
promoter has been shown to play a pivotal role in the
convergence of different signaling pathways to the AP-1
motif, and subsequent induction of MMP-1 transcrip-
tion. For example, insulin stimulation activates the
protein kinases JNK-1 and JNK-2 in rat fibroblasts,
which is followed by phosphorylation and activation of
c- Jun (23, 24). In contrast, in murine kidney mesan-
gial-derived cells the mitogen-activated protein (MAP)
kinase pathway is required for insulin signaling through
the AP-1 motif (25). It is plausible that relaxin stimu-
lation results in similar convergence of as yet unde-
termined signaling pathways that activate transcription
factors such as c-fos, c-jun and Ets-1, eventually lead-
ing to the binding of these transcription factors to their
respective motifs in the MMP-1 promoter to initiate the
transcriptional activity of this gene. Recent studies
point to several possible signaling pathways involved in
the regulation of various genes by relaxin (26–29). The
contribution of these signaling pathways to relaxins
modulation of AP-1 and PEA-3 promoter sites and
induction of MMP-1 remain to be determined.
Our findings also show that exposure of the
disc fibrocartilaginous cells to b-estradiol potentiates
relaxins transcriptional activation of MMP-1 and
slightly increases the gene expression of c-fos and c-jun
transcription factors. The mechanisms by which
estrogen enhances relaxins transcription of MMP-1 are
not currently known. However, the current under-
standing of estrogen signaling may provide some
insights into its modulation of the cells responses to
relaxin. Estrogen signaling is known to occur through at
least two distinct ligand-dependent pathways, namely
(1) ligand-activated estrogen receptor (ER) binding
specifically to DNA at estrogen-responsive elements
(EREs) through ERs DNA binding domain that brings
coactivators and corepressors to the transcription site,
and (2) transcription factor cross talk involving the
interaction of liganded ER with transcription factors
such as AP-1, nuclear factor-jB or SP-1 that then
modulates the activities of these transcription factors
by stabilizing their DNA binding and ⁄ or recruiting
coactivators to the complex (30, 31). With regard to the
latter mechanism, it is plausible that b-estradiol prim-
ing could lead to an indirect recruitment of liganded
ERs to AP-1-responsive DNA elements via heterodimers
of fos and jun that subsequently stimulate MMP-1
transcription. Also, EREs have been shown to be pres-
ent in the promoter of the receptor for insulin-like
growth factor (32), a family of hormones to which
relaxin belongs. If EREs are similarly found to be
present in the promoter of relaxin receptors, it may
indicate a basis for estrogens modulation of MMP-1
induction by relaxin. These and other potential mech-
anisms for estrogens modulation of cellular responses
to relaxin need further exploration.
Interestingly, our data also showed that b-estradiol
alone produces some degree of induction of c-jun and
c-fos gene expression but at the concentration used,
failed to induce transcriptional activity of MMP-1. This
might be because the small increases in mRNA of the
c-jun and c-fos genes is not sufficient to result in a
significant increase of transcription factor protein level
that is essential for the transactivation of MMP-1. On
the other hand, the antagonistic interaction between
ER-a and ER-b on AP-1 mediated transactivation of
MMP-1 could also be a key element that determines the
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final effect of b-estradiol treatment on the MMP
responses of fibrocartilaginous disc cells (33).
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